Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Kévin Debreux"'
Autor:
Jorge Ramirez-Franco, Kévin Debreux, Marion Sangiardi, Maya Belghazi, Yujin Kim, Suk-Ho Lee, Christian Lévêque, Michael Seagar, Oussama El Far
Publikováno v:
Neurobiology of Disease, Vol 196, Iss , Pp 106513- (2024)
In animal models of LGI1-dependent autosomal dominant lateral temporal lobe epilepsy, Kv1 channels are downregulated, suggesting their crucial involvement in epileptogenesis. The molecular basis of Kv1 channel-downregulation in LGI1 knock-out mice ha
Externí odkaz:
https://doaj.org/article/2e7ee02f8fec4a0aa115a578527a6516
Patient-derived antibodies reveal the subcellular distribution and heterogeneous interactome of LGI1
Autor:
Jorge Ramirez-Franco, Kévin Debreux, Johanna Extremet, Yves Maulet, Maya Belghazi, Claude Villard, Marion Sangiardi, Fahamoe Youssouf, Lara El Far, Christian Lévêque, Claire Debarnot, Pascale Marchot, Sofija Paneva, Dominique Debanne, Michael Russier, Michael Seagar, Sarosh R Irani, Oussama El Far
Publikováno v:
Brain-A Journal of Neurology
Brain-A Journal of Neurology, 2022, pp.awac218. ⟨10.1093/brain/awac218⟩
Brain-A Journal of Neurology, 2022, pp.awac218. ⟨10.1093/brain/awac218⟩
Autoantibodies against leucine-rich glioma-inactivated 1 (LGI1) occur in patients with encephalitis who present with frequent focal seizures and a pattern of amnesia consistent with focal hippocampal damage. To investigate whether the cellular and su
Autor:
Jorge Ramirez-Franco, Kévin Debreux, Johanna Extremet, Yves Maulet, Maya Belghazi, Claude Villard, Marion Sangiardi, Fahamoe Youssouf, Lara El Far, Christian Lévêque, Claire Debarnot, Pascale Marchot, Sofija Paneva, Dominique Debanne, Michael Russier, Michael Seagar, Sarosh R Irani, Oussama El Far
Autoantibodies against leucine-rich glioma-inactivated 1 (LGI1) occur in patients with encephalitis who present with frequent focal seizures and a pattern of amnesia consistent with focal hippocampal damage. To investigate whether the cellular and su
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::46b7a577bd302c4ec0743f8baca25c26
https://doi.org/10.1101/2022.03.29.486232
https://doi.org/10.1101/2022.03.29.486232
Autor:
Kévin Debreux, Géraldine Ferracci, Marion Sangiardi, Richard Desplantes, Jacques Fantini, Christian Lévêque, Marie-Pierre Blanchard, Fahamoe Youssouf, Cécile Iborra, Oussama El Far, Jorge Ramírez-Franco, Yves Maulet, Alessandra Flores, Michel R. Popoff, Florian Wernert, Michael Seagar
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America
Proceedings of the National Academy of Sciences of the United States of America, 2019, 116 (36), pp.18098-18108. ⟨10.1073/PNAS.1908051116⟩
Proceedings of the National Academy of Sciences of the United States of America, National Academy of Sciences, 2019, 116 (36), pp.18098-18108. ⟨10.1073/PNAS.1908051116⟩
Proceedings of the National Academy of Sciences of the United States of America, 2019, 116 (36), pp.18098-18108. ⟨10.1073/PNAS.1908051116⟩
Proceedings of the National Academy of Sciences of the United States of America, National Academy of Sciences, 2019, 116 (36), pp.18098-18108. ⟨10.1073/PNAS.1908051116⟩
International audience; Botulinum neurotoxin type B (BoNT/B) recognizes nerve terminals by binding to 2 receptor components: a polysialoganglioside, predominantly GT1b, and synaptotagmin 1/2. It is widely thought that BoNT/B initially binds to GT1b t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::31ece8a080cc84fd202aa04b00b7394c
https://www.hal.inserm.fr/inserm-02274412/document
https://www.hal.inserm.fr/inserm-02274412/document